Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC
Clinical trial NCT03256721 · TERMINATED
Trial details
- NCT number
- NCT03256721
- Sponsor
- Fuzhou General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2019-03-27
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.